Atossa Therapeutics
ATOS
ATOS
49 hedge funds and large institutions have $14.2M invested in Atossa Therapeutics in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 18 reducing their positions, and 8 closing their positions.
Holders
49
Holders Change
-5
Holders Change %
-9.26%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
8
Reduced
18
Closed
8
Calls
$1.06M
Puts
$66K
Net Calls
+$996K
Net Calls Change
+$299K
Top Buyers
| 1 |
1
Bank of Montreal
Toronto,
Ontario, Canada
|
$360K |
| 2 |
GCP
2
GSA Capital Partners
London,
United Kingdom
|
$395K |
| 3 |
3
Morgan Stanley
New York
|
$202K |
| 4 |
4
Squarepoint
New York
|
$55.5K |
| 5 |
5
Renaissance Technologies
New York
|
$1.13M |
Top Sellers
| 1 |
1
Millennium Management
New York
|
$41.6K |
| 2 |
2
BlackRock
New York
|
$2.46M |
| 3 |
XT
3
XTX Topco
George Town,
Cayman Islands
|
$75.1K |
| 4 |
VF
4
Virtu Financial
New York
|
$0 |
| 5 |
5
Bank of New York Mellon
New York
|
$46K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
HighTower Advisors
Chicago,
Illinois
| – | -$15K | -20,100 | Closed |
|
52
Jane Street
New York
| – | -$12.7K | -17,302 | Closed |
|
53
Victory Capital Management
San Antonio,
Texas
| – | -$10.2K | -13,823 | Closed |
|